Maternal hypnotic drugs may adversely affect the fetus and neonate by two mechanisms. First, drugs administered to the mother may diffuse from the maternal circulation to the fetal circulation, causing direct drug effects. These are predictable from the pharmacology of the drug concerned. Second, a hypnotic drug may indirectly affect the fetus, producing symptoms of fetal distress or asphyxia; management is based on restoring perfusion and gas exchange. If a drug is present in a sufficient concentration in the fetus, it will exert direct pharmacological effects. It is believed that serial dilution and protein tissue-binding protein protect the fetus from the effects of drugs administered to the mother. However, if an excessive amount of a hypnotic drug is administered, or if the tissue binding of the fetus is not protective, even a small amount of drug may exert profound effects. These effects will vary with the drug concerned. 1 Diphenhydramine (Benadryl) is an antihistamine drug with anticholenergic as well as sedative side effects. In an injectable form it has a rapid onset of action and is widely distributed throughout the body, including the central nervous system. A portion of the drug is secreted unchanged in the urine, while the rest is metabolized by the liver. The most frequent adverse reactions in the central nervous system are sedation and sleepiness. 2 The following is a case of neonatal depression at birth apparently due to diphenhydramine toxicity in the neonate.
CASE REPORT
A 36-year-old primigravida who was rapid plasma reagin-negative, Rubella immune, hepatitis B surface antigen-negative, Rh-positive, and group B Streptococcus culture negative was at 38 weeks' gestation when the decision to do an elective cesarean section was made. She had presented to her obstetrician 2 weeks earlier with mild hypertension (145/95), a platelet count of 125,000, and "borderline" liver function tests (i.e., aspartate transaminase ϭ 66, alanine transaminase ϭ 96, alkaline phosphatase ϭ 230). She was scheduled for elective cesarean section because of these findings as well as the breech position of the fetus at 38 weeks' gestation. After epidural anesthesia using 2% xylocaine followed by epidural fentanyl, the cesarean section was performed. There were no fetal strip abnormalities before the section, and the mother was not in labor. Membranes were ruptured at delivery, with clear fluid encountered. A female infant weighing 3754 gm was delivered from the breech position. The baby appeared grossly normal but was totally apneic, with a heart rate of 88 beats per minute, and made no respiratory effort after being dried and stimulated. Because there was no respiratory effort, the infant was immediately intubated with a 3.5-mm endotracheal tube and was given intermediate positive pressure ventilation with 100% oxygen. (No meconium was suctioned from the endotracheal tube.) This resulted in an immediate increase in the heart rate to 140 beats per minute, with excellent color and perfusion, but no spontaneous respiratory effort. Narcan (0.4 mg) was given with no response. The Apgars assigned were: 1, 5, and 7 at 1, 5, and 10 minutes, respectively, with deficiency mainly for poor tone and respiratory effort.
Positive pressure ventilation with a resuscitation bag was continued for 12 minutes, at which time the baby made some weak spontaneous respiratory effort. The baby was extubated at 15 minutes of age and placed in a hood with 35% oxygen but still had shallow respiration. A chest x-ray was normal, and the initial arterial blood gas results were reported as: a pH of 7.30, PCO 2 of 30, PCO 2 of 94, and base excess of Ϫ3 while the baby was in a hood of 5% FIO 2 . A blood culture and complete blood count were done and were reported as: a 16,900 white blood cell count, 65% polymorphs, 39% lymphs, and 4% bands; hemoglobin B was 18 and the hematocrit was 52%. The baby was started on 10% glucose intravenously and on intravenous ampicillin and cefotaxime, pending blood culture report (negative at 72 hours). Electrolytes were reported as: Na, 137 meq; Cl, 104 meq; K, 3.4 meq; blood-urea-nitrogen, 16; Ca, 9 mg; and glucose, 85 mg%. Repeat arterial blood gases while in 25% FIO 2 were: pH of 7.29, PCO 2 of 41, and PO 2 of 78 at 4 hours of age.
Because the baby appeared so depressed, the mother was again questioned regarding medication taken before delivery. She reported taking 25 mg of Benadryl every 4 hours for several weeks for severe itching. She denied the use of any other drugs. She was still taking this amount up to the day of delivery. Mother is 5 ft, 11 inches tall and weighed 195 lbs. She had no effect of drowsiness from the drug. Because of this history, a cord blood specimen was sent to the lab for diphenhydramine level.
The infant was maintained in a hood with oxygen for the first 12 hours and continued with shallow but effective respiration. Repeat arterial blood gas results at 10 hours of age were as follows: pH of 7.34, PCO 2 of 44, and PCO 2 of 80 in 23% oxygen. The baby remained very "sleepy," although she did respond slowly to stimulation. At 12 hours of age, the infant became more responsive, alert, and was making better respiratory effort. The oxygen was discontinued at 15 hours of age, the antibiotics were discontinued on day 3, and the baby remained asymptomatic, with a subsequent normal nursery course, and was discharged on day 4 to be followed as an outpatient. The baby was seen at 1 week of age and was symptom-free, active, and breast-feeding well.
One week later, the laboratory reported a cord level of 640 ng/ml of diphenhydramine in the cord blood. This laboratory also stated that the usual antihistamine hypnotic range was reported to be 100 to 1000 ng/ml, with levels over 1000 ng/ml considered toxic.
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DISCUSSION
The importance of considering maternal drugs as an influence on the fetus and newborn is appreciated by those caring for babies at birth. The use of anesthetic or analgesic drugs must always be a consideration in a depressed newborn. 4 This case appears to be a baby depressed by maternal ingestion of diphenhydramine, causing severe depression in the neonate. Search of the literature revealed no case of newborn hypnotic symptoms from maternal diphenhydramine ingestion. Diphenhydramine withdrawal was reported in a newborn whose mother had taken 150 mg per day during pregnancy. 5 Generalized tremors and diarrhea began on day 5 of life. This drug readily crosses the placenta from mother to baby. A study of the oxytocic properties of diphenhydramine was reported in 1980. A total of 50 women were given 50 mg intravenously over 3.5 minutes to study oxytocic effects on the uterus. Although no uterine hyperstimulation was observed, no fetal distress was reported. 6 Rurak et al. 7 studied the effects of diphenhydramine on fetal behavioral states, breathing activity, blood gases, blood pressure, and heart rate in the fetal lamb after maternal or fetal drug administration. They showed significant effects on the fetal lamb. Levels of 400 ng/ml of diphenhydramine in the fetal lamb were associated with a decline in arterial PO 2 and pH. Levels of only 36 ng/ml in the fetus elicited fetal sedative effects. They felt that higher levels associated with sedative effects in adults would cause major sedation in the fetal lamb. The level in the baby reported here was 640 ng/ml on cord blood.
Diphenhydramine is commonly used during pregnancy for pruritis. The drug is available over the counter and is classified as a category B drug based on animal studies; there have been no reports of harm to the fetus in the first trimester. There are no adequate studies in pregnant humans. Diphenhydramine is not recommended during pregnancy unless strongly indicated. 8 Its use just before delivery can produce a significant level in the mother, and subsequent transfer to the infant, which appears to be the case in this patient. Maternal diphenhydramine ingestion may be the cause of severe depression and hypoventilation of the baby at birth. A complete history of all drugs taken by the mother before delivery is important in evaluating neonatal behavior at birth.
